Back
ESC Premium Access

Early administration of lipid lowering agents in acute coronary syndromes.

Session: Cardiovascular drugs in acute coronary syndromes: when to start and when to stop
Topic: Pharmacology and Pharmacotherapy
Speaker: Professor C. Cannon (Boston, US)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Christopher Paul Cannon

Brigham and Women's Hospital, Boston (United States of America)
38 presentations
0 follower

3 more presentations in this session

When to start and when to stop P2Y12 inhibitors in acute coronary syndromes

Speaker: Professor D. Angiolillo (Jacksonville, US)

Access
Slides
Video
Thumbnail

When to start and when to stop beta-blockers in acute coronary syndromes and (nearly) normal ventricular function

Speaker: Professor E. Puymirat (Paris, FR)

Access
Slides
Video
Thumbnail

When to start and when to stop ACE-I/ARB in acute coronary syndromes and (nearly) normal ventricular function

Speaker: Doctor B. Gersh (Rochester, US)

Access
Slides
Video
Thumbnail

Access the full session

Cardiovascular drugs in acute coronary syndromes: when to start and when to stop

Speakers: Professor C. Cannon, Professor D. Angiolillo, Professor E. Puymirat, Doctor B. Gersh
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb